US 8481529
Combination cancer chemotherapy
granted A61KA61K31/166A61K31/5383
Quick answer
US patent 8481529 (Combination cancer chemotherapy) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arizona Board of Regents on Behalf of the University of Arizona
- Grant date
- Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K31/166, A61K31/5383, A61K45/06, A61P